Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ophioderma brevispina

ABSTRACT: Ophioderma brevispina Transcriptome or Gene expression

PROVIDER: PRJNA299887 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2845424_1.fastq.gz	Fastqsanger.gz
	SRR2845424_2.fastq.gz	Fastqsanger.gz
	SRR2845428_1.fastq.gz	Fastqsanger.gz
	SRR2845428_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Ophioderma brevispina

Project description:Ophioderma brevispina overview

| PRJNA597096 | ENA

Ophioderma brevispina isolate:Catalog1970-2016

Project description:Ophioderma brevispina isolate:Catalog1970-2016 Genome sequencing and assembly

| PRJNA779014 | ENA

Ophioderma pendulum

Project description:Ophioderma pendulum Raw sequence reads

| PRJNA752349 | ENA

Ophioderma longicauda

Project description:transcriptome reads of the brittle stars Ophioderma longicauda C3 and C5

| PRJNA360063 | ENA

Hilara brevispina

Project description:The mitochondrial genome of the Hilara Brevispina (Diptera, Empididae)

| PRJNA952407 | ENA

Chloromonas brevispina UTEX SNO96

Project description:Chloromonas brevispina and associated bacteria

| PRJNA383412 | ENA

Active Notch Signaling is Required for Arm Regeneration ina Brittle Star

Project description:Cell signaling pathways play key roles to coordinate cellular events in development. Notch signaling pathway is highly conserved across all multicellular animals and is known to co- ordinate a multitude of diverse cellular events, including proliferation, differentiation, fate specification, and cell death. Specific functions of the pathway are however highly context- dependent and are not well characterized in post-traumatic regeneration. Here, we use a small-molecule inhibitor of the pathway (DAPT) to demonstrate that Notch signaling is required for proper arm regeneration in the brittle star Ophioderma brevispina, a highly re- generative member of the phylum Echinodermata. We also employ a transcriptome-wide gene expression analysis (RNA-seq) to characterize the downstream genes controlled by the Notch pathway in the brittle star regeneration.

2019-12-20 | GSE142391 | GEO

Mitochondrial phylogeny of the brittle star genus Ophioderma.

Project description:We reconstructed the mitochondrial phylogeny of the species of the brittle star genus Ophioderma, using sequences of the Cytochrome Oxidase I gene (COI) to address four questions: (i) Are the species of Ophioderma described on morphological evidence reflected in mitochondrial genealogy? (ii) Which species separated from which? (iii) When did speciation events occur? (iv) What is the rate of COI evolution in ophiuroids? We found that most of the 22 described species we sampled coincide with monophyletic clusters of COI sequences, but there are exceptions, most notably in the eastern Pacific, in which three undescribed species were indicated. The COI phylogeny lacks resolution in the deeper nodes, but it does show that there are four species pairs, the members of which are found on either side of the central American Isthmus. Two pairs with a genetic distance of ~ 4% between Atlantic and Pacific members were probably split during the final stages of Isthmus completion roughly 3 million years ago. The rate of divergence provided by these pairs allowed the calibration of a relaxed molecular clock. Estimated dates of divergence indicate that the lineages leading to extant species coalesce at times much older than congeneric species in other classes of echinoderms, suggesting that low extinction rates may be one of the reasons that ophiuroids are species-rich. The mean rate of COI substitution in Ophioderma is three times slower than that of echinoids. Conclusions of previous mitochondrial DNA studies of ophiuroids that relied on echinoid calibrations to determine divergence times need to be revised.

| S-EPMC8964800 | biostudies-literature

Biomarks of Resistance to Cetuximab in Colorectal Cancer

Project description:Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

| 2671639 | ecrin-mdr-crc

Project description:Chloromonas brevispina - bacteria co-culture

| PRJNA427065 | ENA